Brainaurora-b

Status: Publicly traded

Direct answer

Brainaurora-b is publicly traded on HKSE under the ticker 6681.HK.

BrainAurora Medical Technology Limited, also referred to as Brainaurora-b, develops advanced medical-grade digital therapeutic (DTx) products. The company focuses on the assessment and intervention of cognitive impairments across various conditions, including vascular diseases, neurodegenerative disorders, psychological ailments, and developmental deficiencies in children. Key offerings include the Brain Function...

Can you invest in Brainaurora-b?

Yes. Brainaurora-b is publicly traded on HKSE under the ticker 6681.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Brainaurora-b

Detailed equity research is provided by MarketSnap.